We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Sally Beauty Holdings
SBH
$1.56B
| $23.4M | 0.03% |
681,554
-406,871
| -37% | -$13.1M |
|
277
Central Pacific Financial
CPF
$974M
| $23.4M | 0.03% |
1,017,491
+116,050
| +13% | +$2.59M |
|
278
Nu Skin
NUS
$233M
| $23.2M | 0.03% |
384,960
-15,572
| -4% | -$793K |
|
279
Popular Inc
BPOP
$10.8B
| $23.1M | 0.03% |
672,624
+127,100
| +23% | +$4.21M |
|
280
Integra LifeSciences
IART
$1.34B
| $23.1M | 0.03% |
916,187
-38,248
| -4% | -$904K |
|
281
ABM Industries
ABM
$2.78B
| $22.8M | 0.03% |
717,143
-24,993
| -3% | -$753K |
|
282
The GEO Group
GEO
$4.31B
| $22.5M | 0.03% |
771,540
+48,240
| +7% | +$1.38M |
|
283
Walker & Dunlop
WD
$1.41B
| $22.2M | 0.03% |
1,253,198
-43,561
| -3% | -$740K |
|
|
TPC
284
Tutor Perini Cor
TPC
$4.7B
| $22.2M | 0.03% |
950,760
+696,380
| +274% | +$16.4M |
|
285
Matthews International
MATW
$661M
| $22.1M | 0.03% |
428,273
+29,888
| +8% | +$1.44M |
|
286
Nelnet
NNI
$4.57B
| $22M | 0.03% |
464,236
-159
| -0% | -$7.34K |
|
287
Sportsman's Warehouse
SPWH
$45.3M
| $21.7M | 0.03% |
2,711,657
-216,977
| -7% | -$1.6M |
|
288
LSB Industries
LXU
$745M
| $21.4M | 0.03% |
673,838
-31,452
| -4% | -$860K |
|
|
NCI
289
DELISTED
Navigant Consulting, Inc.
NCI
| $21.3M | 0.03% |
1,644,919
-62,826
| -4% | -$891K |
|
|
RSTI
290
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $21.2M | 0.03% |
876,113
-271,341
| -24% | -$6.83M |
|
|
STBZ
291
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $21M | 0.03% |
998,840
+581,200
| +139% | +$11.5M |
|
|
AEGN
292
DELISTED
Aegion Corp
AEGN
| $20.9M | 0.03% |
1,158,266
+31,858
| +3% | +$545K |
|
|
FCB
293
DELISTED
FCB Financial Holdings, Inc.
FCB
| $20.9M | 0.03% |
762,073
+160,268
| +27% | +$3.95M |
|
294
Employers Holdings
EIG
$883M
| $20.7M | 0.03% |
767,389
+72,630
| +10% | +$1.7M |
|
295
AGNC Investment
AGNC
$12.9B
| $20.7M | 0.03% |
968,336
+201,053
| +26% | +$4.35M |
|
|
CLD
296
DELISTED
Cloud Peak Energy Inc
CLD
| $20.4M | 0.03% |
3,509,954
+700,692
| +25% | +$5.17M |
|
|
LPNT
297
DELISTED
LifePoint Health, Inc.
LPNT
| $20.4M | 0.03% |
277,846
-12,821
| -4% | -$910K |
|
298
Knowles
KN
$2.95B
| $20.3M | 0.03% |
1,054,385
+86,267
| +9% | +$1.8M |
|
299
Helix Energy Solutions
HLX
$1.5B
| $20.3M | 0.03% |
1,357,849
-60,343
| -4% | -$1.02M |
|
|
RPXC
300
DELISTED
RPX Corporation
RPXC
| $20.2M | 0.03% |
1,406,266
-51,926
| -4% | -$714K |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.